D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways

(2011) Feng Gao et al.   Integrative Biology

Apolipoprotein A-I Mimetic Peptides

(2010) Courtney B. Sherman et al.   Cardiology in Review

Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice

(2010) N. D. Vaziri et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

(2010) F. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Apolipoprotein A-I mimetic peptides

(2008) Brian J. Van Lenten et al.   Current Atherosclerosis Reports

Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models

(2008) Mohamad Navab et al.   CURRENT DRUG TARGETS

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH

Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth

(2007) Christine J. Weydert et al.   FREE RADICAL BIOLOGY AND MEDICINE